. The neic BALB/c mice, they form mammary carcinomas behavior of these tumor lines reflects the sequence of within a month (Aslakson and Miller, 1992) . While these multistep metastasis progression. We therefore set out cell lines form primary tumors with equivalent kinetics, to compare the gene expression profiles of the four cell lines in order to dissect the specific genetic and they differ dramatically in their metastatic potential. epigenetic changes associated with their respective analysis showed that Twist mRNA was expressed in 168FARN, 4TO7, and 4T1 tumors, but not 67NR tumors metastatic abilities.
To compare the gene expression profiles, we injected ( Figure 1C ). Real-time RT-PCR analysis confirmed that Twist mRNA was expressed 5-15-fold higher in 168FARN, cells from each of the four lines into the mammary glands of BALB/c mice ( Figure 1A ). At 30 days postinjection, 4TO7, and 4T1 tumor cells compared to 67NR cells (Figure 1D ). We also observed that Twist protein was exall the cells formed primary tumors weighing 2-3 grams. We confirmed their respective metastatic phenotypes pressed in the 168FARN, 4TO7, and 4T1 tumor cells, but not in the 67NR cells ( Figure 1E ). In addition, we as previously reported (Aslakson and Miller, 1992 Figure 1B) . We compared the transcription profile of the four tumor lines and assigned nature of the multistep metastasis process, Twist, as a key transcription factor controlling morphogenesis, may differentially expressed genes (changes greater than 2.5-fold) to such three groups. The Group X genes conbe able to elicit multiple biochemical and cell biological alterations of metastasis. sisted of 36 upregulated genes and 9 downregulated genes. The Group Y genes included 7 upregulated and 3 downregulated genes. The genes in the Group Z con- Figure 3E ).
To determine whether loss of Twist expression affected the ability of 4T1 cells to metastasize, we first examined the metastatic behaviors of the 4T1 tumor cells expressing either Twist-siRNA3 or the controlsiRNA. Four weeks after implantation of such cells in the mammary glands of BALB/c mice, we sacrificed the mice and examined lungs for metastatic lesions by inspection under a dissection microscope. While tumors expressing control-siRNA formed large numbers of macroscopically visible metastases in their lungs, those that expressed Twist-siRNA3 formed very few metastases ( Figure 3A) . The average number of visible metastatic nodules dropped from 105 Ϯ 14 per lung in mice carrying 4T1 control-siRNA tumors to 14 Ϯ 2 nodules per lung in mice carrying 4T1 Twist-siRNA3 tumors (Figure 3B) . Histological analyses confirmed that the number of micrometastatic lesions was also drastically reduced in the lungs of mice carrying 4T1 Twist-siRNA3 tumors ( Figure 3C ). In addition, the sizes of individual metastatic nodules present in the lungs of both groups of mice were very similar. These results suggested that loss of Twist expression reduced the number of metastatic nodules present in the lung, rather than preventing micrometastases established in the lung from proliferating into visible nodules.
To exclude the possibility that the observed effect is due to nonspecific suppression of off-target genes by Twist siRNA-3, we further tested whether two additional Twist siRNA sequences (Twist siRNA5 and Twist siRNA7) can also suppress the ability of 4T1 cells to metastasize. Indeed, expression of either Twist siRNA5 or siRNA7 in 4T1 tumor cells also drastically reduced the formation of pulmonary metastatic nodules by 4T1 tumors in mice ( Figure 3D ). Together, these results dem- staining in the control cells ( Figure 5B ). We also observed complete loss of E-cadherin, ␣-catenin, and ␥-catenin proteins by immunoblotting ( Figure 5C ). In contrast, the expression of fibroblast markers, including fibronectin, vimentin, smooth-muscle actin, and N-cadherin, whose expression has been shown to correlate positively with the EMT (Boyer and Thiery, 1993), was strongly induced (Figures 5B and 5C ). Hence, both the morphological and molecular changes in the Twistexpressing MDCK cells demonstrated that these cells had undergone an EMT. We wished to determine whether the ability of Twist to induce an EMT in MDCK cells could be extended to epithelial cells more relevant to breast cancers. Accordingly, we introduced Twist into immortalized human mammary epithelial cells (HMECs) (Elenbaas et al.,  2001) . We observed the identical set of changes associated with EMT in these cells (Figures 5A and 5C ). Furthermore, both MDCK and HMEC cells expressing Twist, but not control cells, exhibited high levels of growth factor-induced directional migration ( Figure 5D ). Taken together, these data indicated that Twist is capable of inducing an EMT and associated migratory behavior in normal epithelial cells and suggested that Twist-induced EMT could contribute to the phenotypes of invasion and metastasis. group (p ϭ 0.008) (Figure 7D ). This inverse possible that Twist, acting as a bHLH transcription faccorrelation between high Twist expression and low tor, binds directly to the E-boxes on the E-cadherin E-cadherin expression in human invasive lobular carcipromoter to suppress its transcription. noma is consistent with our finding that Twist can induce In addition to silencing E-cadherin transcription, we loss of E-cadherin-mediated cell-cell adhesion in epithehave also found that Twist induces the expression of lial cells. It also suggests that expression of Twist can mesenchymal markers, such as fibronectin and N-cadcontribute to the pathogenesis of human invasive lobuherin, during an EMT. These events appear to be indelar carcinomas.
Loss of E-cadherin appears to be critical to an EMT. One major mechanism for inhibiting E-cadherin expression involves silencing of E-cadherin transcription through three E-boxes in its promoter (Thiery, 2002). We observed an over 100-fold reduction of E-cadherin
pendent of E-cadherin expression, because we have found that ectopic expression of E-cadherin could not revert the EMT phenotype in Twist-expressing HMEC Discussion cells. Hence, Twist does not rely on E-cadherin repression to induce mesoderm-specific genes and may, as
Activation of Twist in Tumor Metastasis
is the case during Drosophila gastrulation (Leptin, 1991), The present study utilized gene expression array analyfunction as a potent transcriptional activator to induce ses to identify genes involved in metastasis in a mouse such genes. mammary tumor model. Twist, a transcription factor important in embryonic development, was identified to be essential for the metastatic process. We have demon-
Involvement of Twist in Human Cancers strated that Twist induces loss of E-cadherin-mediated
The experimental model that we used here, implantation cell-cell adhesion and an EMT in epithelial cells. In huof tumor cells in an orthotopic site in a syngeneic host, man invasive lobular carcinomas, we also observed an recapitulates many biological conditions in cancer painverse correlation between the expression levels of tients. For example, the host tissue environment of priTwist and E-cadherin. Together, the present evidence mary tumors strongly affects their ability to metastasize leads us to propose that activation of Twist and Twistand the target organ sites to which they spread (Gohji induced EMT are important components of tumor meet al., 1997). Thus, we implanted mammary tumor cells tastasis.
in their orthotopic site-the mammary fat pad. The host The metastasis program is a complex series of biologiimmune system is also thought to play important roles cal steps, thus tumor cells must acquire a series of traits in tumorigenesis and metastasis (Miller, 1993) . In this that enable them to overcome multiple barriers erected study, the tumor cells proliferated in a wild-type BALB/c by the normal tissues that they encounter en route. Our mouse, so we could examine their metastatic behaviors results suggest that during the development of the metain an intact immune environment. GGTGGTGAAGA. mouse Twist were designed and verified to be specific to Twist by Total RNA was extracted using RNeasy Mini kit coupled with Blast search against the mouse genome. Twist-siRNA3-targetting RNase-free DNase set (Qiagen) and reverse transcribed with Hexasequence is AAGCTGAGCAAGATTCAGACC; Twist-siRNA5-tarnucleotide Mix (Roche). The resulting cDNAs were used for PCR getting sequence is AGGTACATCGACTTCCTGTAC; and Twistusing SYBR-Green Master PCR mix (Applied Biosystem) in triplisiRNA7-targetting sequence is AGCGGGTCATGGCTAACGTGC.
cates. PCR and data collection were performed on iCycler (BioRad). The U6 promoter with Twist-siRNA3, Twist-siRNA5, or Twist-siRNA7
All quantitations were normalized to an endogenous control GAPDH. insert were subcloned into pSP108-PURO. A control siRNA oligo, The relative quantitation value for each target gene compared to which does not match any known mouse coding cDNA, was used the calibrator for that target is expressed as 2 -(Ct-Cc) (Ct and Cc are as control. the mean threshold cycle differences after normalizing to GAPDH).
Luciferase reporter gene constructs containing the E-cadherin
The relative expression levels of samples are presented by a semipromoter sequence and various E-box mutant forms (EboxC.MUT, log plot. This assay was performed as described (Clark et al., 2000) .
Measurement of Primary Tumor Growth and Isolation Luciferase Reporter Assay of Tumors Cells from the Mammary Gland, Blood, and Lung
Cells of 50% confluence in 12-well dishes were transfected using Post tumor cell injection, groups of 5-10 mice were sacrificed weekly. The mammary tumors were removed and weighed individuFugene6 (Roche 
